Carla Walraven

Pharmacist



  
  2211 Lomas Blvd Ne, Albuquerque
New Mexico, 87106-2719

 505-272-4669   
Carla Walraven is a pharmacist in Albuquerque, New Mexico. Patients can reach her at 2211 Lomas Blvd Ne, Albuquerque or contact her on 505-272-4669. Active license number of Carla Walraven is RP00007123 for Pharmacist in New Mexico.
Carla Walraven is


Complete Profile:
Carla Walraven speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name: Carla Walraven
Specialization: Pharmacist
Credentials:PHARMD
Gender:Female
Location:2211 Lomas Blvd Ne, Albuquerque,
New Mexico, 87106-2719
Phone:505-272-4669
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Carla Walraven are as mentioned below.
NPI Number: 1598510562
NPI Enumeration Date: 22 Apr, 2024
NPI Last Update On: 22 Apr, 2024

Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Carla Walraven are as mentioned below.
SpecializationLicense NumberStateStatus
Pharmacist RP00007123New MexicoPrimary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 2211 Lomas Blvd Ne,
Albuquerque, New Mexico
Zip: 87106-2719
Phone Number: 505-272-4669
Patients can reach Carla Walraven at 2211 Lomas Blvd Ne, Albuquerque, New Mexico or can call on phone at 505-272-4669.

Comments/ Reviews:
Read all the reviews posted for Carla Walraven below. You may also share your own experience with Carla Walraven. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.